HIDDEN WIDGETS | Protego

Lorem ipsum dolor sit amet

October 8, 2021

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nullam et mauris sollicitudin neque congue placerat id a nibh. In sodales augue vitae nisi egestas iaculis. Donec pulvinar luctus imperdiet.

Lorem ipsum dolor sit amet

October 8, 2021

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nullam et mauris sollicitudin neque congue placerat id a nibh. In sodales augue vitae nisi egestas iaculis. Donec pulvinar luctus imperdiet.

Lorem ipsum dolor sit amet

October 8, 2021

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nullam et mauris sollicitudin neque congue placerat id a nibh. In sodales augue vitae nisi egestas iaculis. Donec pulvinar luctus imperdiet.

Protego Biopharma Raises $51 Million Series A Financing to Advance the Treatment of Protein Misfolding Diseases

November 17, 2021

Protego Biopharma, Inc., a preclinical-stage biotechnology company dedicated to finding novel solutions for protein misfolding diseases, today announced it has raised $51 million in a Series A financing co-led by Lightspeed Venture Partners, Vida Ventures and MPM Capital.

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet

Lorem ipsum dolor sit amet

Protego Biopharma Raises $51 Million Series A Financing to Advance the Treatment of Protein Misfolding Diseases

LINKS

ABOUT